We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Launches New Innovations

By LabMedica International staff writers
Posted on 06 Aug 2019
Print article
Image: The RX daytona+ clinical chemistry analyzer (Photo courtesy of Randox).
Image: The RX daytona+ clinical chemistry analyzer (Photo courtesy of Randox).
Global diagnostics firm Randox Laboratories (Crumlin, UK) showcased its unique life science capabilities in areas, including stroke differentiation and quality control for a range of infectious diseases, at the world’s largest laboratory medicine conference – the AACC Annual Scientific Meeting & Clinical Lab Expo – in California, USA. The 71st event from the American Association for Clinical Chemistry (AACC) highlighted the best in the industry on the world stage once again, as clinicians, companies and customers from all over the world flocked to the Californian Anaheim Convention Center from August 4-8, 2019.

At this year’s AACC event, Randox launched a number of exciting new innovations, including a new offering of Infectious Disease Serology Internal Quality Controls which includes quality control material vital for the testing of Lyme Disease, ToRCH, EBV, HIV, HAV, HTLV, CMV, VZV and much more. All samples are provided in a user-friendly, liquid ready-to-use format, which significantly reduces preparation time and the risk of pipetting errors. Randox also launched its whole pathogen Blood Borne Virus Controls sold under the brand name Qnostics that are versatile in monitoring the presence of BBVs, including HIV, Hepatitis B and Hepatitis C.

For use with molecular methods, the controls are manufactured using whole pathogens and therefore, mimic the patient sample, providing the best sample matrix for laboratories. Among its QC solutions, Randox highlighted its Acusera Linearity Sets that are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. The company’s linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all the linearity sets are supplied in a liquid format, while also presented in varying levels.

At AACC, Randox unveiled its brand new Randox Stroke Biochip, an advancement of its Biochip Array Technology, which is a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways. It provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.

Randox also announced 510 (K) clearance from the US Food and Drug Administration for its RX daytona+ fully automated, benchtop, clinical chemistry analyzer that is capable of performing high quality testing, including emergency STAT sampling, and boasts of a combined throughput of 450 tests per hour including ISE. At AACC 2019, Randox highlighted its fully automated Evidence+ batch immunoanalyzer that simultaneously detects multiple drugs and drug metabolites from a single sample and also announced its new automated assay for sPLA2-IIA mass.

“We look forward to AACC every year as we exhibit our constantly-evolving revolutionary technologies,” said Randox Managing Director, Dr. Peter FitzGerald. “This year, we will once again highlight Randox’s ground-breaking diagnostic products and services which help to save and extend lives across the world.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.